<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-113845</identifier>
<setSpec>0210-5020</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Prevention of thromboembolism in bariatric surgery</dc:title>
<dc:description xml:lang="en">Disease thromboembolic (ETEV) is one of the major complications that can occur after surgery, and is the leading cause of death in the postoperative period of Bariatric Surgery. Among other factors, should be aware that these patients are at additional risk of ETEV due to own obesity (IMC&gt;30). After Bariatric Surgery the risk of thromboembolic events varies according to the surveyed series. In general, it is estimated that danger EP (pulmonary embolism) is 0.8% and DVT (deep vein thrombosis) of 1.7%. ETEV global mortality estimates of 0.1 to 2%(AU)</dc:description>
<dc:creator>Macho Márquez, S</dc:creator>
<dc:creator>Barrio Martín, M. J. del</dc:creator>
<dc:creator>Jerez González, J</dc:creator>
<dc:creator>Cárcamo Trapero, M</dc:creator>
<dc:creator>Quiñones Sánchez, C</dc:creator>
<dc:creator>Madico Cerezo, M. C</dc:creator>
<dc:creator>Lozano Calvo, B</dc:creator>
<dc:creator>Masdevall Noguera, C</dc:creator>
<dc:creator>García Arnau, E</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La enfermedad tromboembólica (ETEV) es una de las complicaciones más importantes que pueden aparecer tras cualquier cirugía, y constituye la primera causa de muerte en el postoperatorio de cirugía bariátrica. Entre otros factores, se debe tener en cuenta que estos pacientes presentan un riesgo adicional de ETEV debido a la propia obesidad (IMC&gt;30). Tras la cirugía bariátrica el riesgo de padecer eventos tromboembólicos varía según las series consultadas. En líneas generales, se estima que el peligro de EP (embolia pulmonar) es del 0,8% y el de TVP (trombosis venosa profunda) de 1,7%. La mortalidad global por ETEV se estima del 0,1 al 2%(AU)</dc:description>
<dc:source>Rev Enferm;36(3): 195-198, mar. 2013.</dc:source>
<dc:identifier>ibc-113845</dc:identifier>
<dc:title xml:lang="es">Prevención del tromboembolismo en cirugía bariátrica</dc:title>
<dc:subject>^d14308^s22024</dc:subject>
<dc:subject>^d14308^s22054</dc:subject>
<dc:subject>^d52618^s22009</dc:subject>
<dc:subject>^d52618^s22054</dc:subject>
<dc:subject>^d51221^s22039</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d9918^s22060</dc:subject>
<dc:subject>^d14308^s22080</dc:subject>
<dc:subject>^d52618^s22024</dc:subject>
<dc:subject>^d11621^s22039</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d9951^s22012</dc:subject>
<dc:subject>^d52618^s22080</dc:subject>
<dc:subject>^d9918^s22049</dc:subject>
<dc:subject>^d51221^s22074</dc:subject>
<dc:subject>^d12092^s22080</dc:subject>
<dc:subject>^d51221^s22024</dc:subject>
<dc:subject>^d51221^s22045</dc:subject>
<dc:subject>^d11621^s22024</dc:subject>
<dc:subject>^d14308^s22009</dc:subject>
<dc:subject>^d12092^s22054</dc:subject>
<dc:subject>^d12092^s22024</dc:subject>
<dc:type>article</dc:type>
<dc:date>201303</dc:date>
</metadata>
</record>
</ibecs-document>
